Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry

Bart P F Rutten; Suzanne C van Bronswijk

doi:10.1176/appi.ajp.20220783

Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry

Bart P F Rutten^*, Suzanne C van Bronswijk

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	794-797
Number of pages	4
Journal	American Journal of Psychiatry
Volume	179
Issue number	11
DOIs	https://doi.org/10.1176/appi.ajp.20220783
Publication status	Published - 1 Nov 2022

Keywords

Humans
Electroconvulsive Therapy
Psychiatry
Risk Factors
Treatment Outcome

Access to Document

10.1176/appi.ajp.20220783

Cite this

@article{fac590b1d443433683a78dd138d7bea7,

title = "Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry",

keywords = "Humans, Electroconvulsive Therapy, Psychiatry, Risk Factors, Treatment Outcome",

author = "Rutten, {Bart P F} and {van Bronswijk}, {Suzanne C}",

note = "Funding Information: Research by Dr. Rutten is supported by a VIDI grant (91718336) from the Netherlands Scientific Organization and by the European Union{\textquoteright}s Horizon Europe Programme Staying Healthy 2021 under grant agreement 101057182.",

year = "2022",

month = nov,

day = "1",

doi = "10.1176/appi.ajp.20220783",

language = "English",

volume = "179",

pages = "794--797",

journal = "American Journal of Psychiatry",

issn = "0002-953X",

publisher = "American Psychiatric Publishing, Inc.",

number = "11",

}

TY - JOUR

T1 - Proof-of-Principle Study on ECT Illustrates Challenges and Possible Merits of Using Polygenic Risk Scores to Predict Treatment Response in Psychiatry

AU - Rutten, Bart P F

AU - van Bronswijk, Suzanne C

N1 - Funding Information: Research by Dr. Rutten is supported by a VIDI grant (91718336) from the Netherlands Scientific Organization and by the European Union’s Horizon Europe Programme Staying Healthy 2021 under grant agreement 101057182.

PY - 2022/11/1

Y1 - 2022/11/1

KW - Humans

KW - Electroconvulsive Therapy

KW - Psychiatry

KW - Risk Factors

KW - Treatment Outcome

U2 - 10.1176/appi.ajp.20220783

DO - 10.1176/appi.ajp.20220783

M3 - Editorial

C2 - 36317336

SN - 0002-953X

VL - 179

SP - 794

EP - 797

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

IS - 11

ER -